Approval · Notice of Compliance 4688 · 1996
COUMADIN: Notice of Compliance 4688
Issued October 25, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4688
- Date
- October 25, 1996
- Company
- Du Pont Merck Pharma Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New dosage form
- Therapeutic class
- Anticoagulant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COUMADIN | 02229741 | Cancelled Post Market |
Medicinal ingredients
- WARFARIN SODIUM 5 MG per VIAL